# A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

> **NCT05785832** · NA · COMPLETED · sponsor: **Tandem Diabetes Care, Inc.** · enrollment: 319 (actual)

## Conditions studied

- Type 2 Diabetes Treated With Insulin

## Interventions

- **DEVICE:** t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM
- **DEVICE:** Standard Therapy plus continuous glucose monitoring (CGM)

## Key facts

- **NCT ID:** NCT05785832
- **Lead sponsor:** Tandem Diabetes Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-01
- **Primary completion:** 2024-09-24
- **Final completion:** 2024-09-24
- **Target enrollment:** 319 (ACTUAL)
- **Last updated:** 2026-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05785832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05785832, "A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05785832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*